Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups

SIMPLE SUMMARY: The immunohistochemical analysis of Special AT-rich sequence-binding protein 2 (SATB2) is increasingly being used to detect colorectal differentiation. Our study aimed to investigate SATB2 expression levels and the prognostic relevance of SATB2 loss in colorectal carcinoma (CRC), esp...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Maxime, Silva, Miguel, Konukiewitz, Björn, Lang, Corinna, Steiger, Katja, Halfter, Kathrin, Engel, Jutta, Jank, Paul, Pfarr, Nicole, Wilhelm, Dirk, Foersch, Sebastian, Denkert, Carsten, Tschurtschenthaler, Markus, Weichert, Wilko, Jesinghaus, Moritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699173/
https://www.ncbi.nlm.nih.gov/pubmed/34944797
http://dx.doi.org/10.3390/cancers13246177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699173/
https://www.ncbi.nlm.nih.gov/pubmed/34944797
http://dx.doi.org/10.3390/cancers13246177

Ejemplares similares